Has Melissa Murphy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $652,945 in general payments to Melissa Murphy, MD across 1,274 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Melissa Murphy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Melissa Murphy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Melissa Murphy, MD

Pain Medicine · Grapevine, TXNPI 1245641091

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $471,396 of the $652,945 with a category attached, or 72.2%. Medtronic accounts for 91.2% of it on its own, with 14 other manufacturers making up the rest. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$652,945in general payments, 2019–2025

Across 1,274 payments — averaging $512.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$595K
Pacira Pharmaceuticals Incorporated$49K
Relievant Medsystems, Inc.$2K
Abbott$2K
MML US, Inc.$2K
Boston Scientific$1K
plus $2K from 9 others

$57,846in research payments, 2019–2025

Across 24 payments — averaging $2410.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$58K

What the payments were for

Consulting fees$61,6989%
Speaking & faculty fees$471,39672%
Travel & lodging$86,42913%
Food & beverage$33,4225%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	1,130	$595,250
Pacira Pharmaceuticals Incorporated	57	$48,600
Relievant Medsystems, Inc.	9	$2,361
Abbott	24	$2,098
MML US, Inc.	10	$1,727
Boston Scientific	19	$1,408
Stryker	6	$786
Stimwave Technologies Incorporated	3	$158
SPR Therapeutics, Inc	2	$138
Nalu Medical, Inc.	3	$99
Si-bone, Inc.	1	$88
Nevro Corp.	3	$63
GRT US Holding, Inc.	1	$58
Curonix LLC	3	$57
Heron Therapeutics, Inc.	3	$56

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTELLIS ADAPTIVESTIM$402,187
VANTA ADAPTIVESTIM$74,589
Iovera$46,561
SYNCHROMEDII$19,927
INCEPTIV$19,631
KYPHON EXPRESS II KYPHOPAK TRAY$14,342
EXPAREL$11,149
Zilretta$10,932
Intracept$6,331
RESTORE$2,500
OSTEOCOOL RF ABLATION SYSTEM$1,755
ReActiv8$1,653
RESTORESENSORSURESCAN$1,640
INTELLIS$1,608
Accurian$1,538
PERCEPT PC BRAINSENSE$1,530
N'VISION$1,500
Proclaim Family of SCS IPGs$1,026
SPECTRA WAVEWRITER$826
IVS - VERTEBRAL AUGMENTATION PRODUCTS$648

How this compares

$652,945 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$328,187

Medicare patients

526

Services billed

2,975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	167	$4,580
Celecoxib	204	$2,634
Gabapentin	162	$1,931
Meperidine Hcl	14	$1,890
Methocarbamol	52	$913
Tizanidine Hcl	79	$871
Pregabalin	38	$802
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	30	$739
Duloxetine Hcl	29	$714
Cyclobenzaprine Hcl	73	$615
Tramadol Hcl	84	$396
Acetaminophen-CodeineAcetaminophen With Codeine	23	$342
Methylprednisolone	15	$117
Mupirocin	16	$114
Meloxicam	44	$78

Paid to pharmacies, not to this prescriber.

Other pain medicine in Grapevine

Shiraz YazdaniLubbock$514K
Aaron CalodneyTyler$296K
Candice BurnetteSugar Land$265K
Ashley Bailey-ClassenFort Worth$244K
Grant ChenHouston$175K
Gunjan PatelHouston$166K
Anthony BergRockwall$165K
Puneet SayalCorpus Christi$153K
Eduardo GarciaWebster$147K
Jaideep MehtaHouston$134K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →